Education
About Us
Working with TipRanks
Follow Us
Peter Rahmer Insider Profile
4 Followers
Peter Rahmer, Chief Corporate Develpment Officer at Relay Therapeutics, holds 378.00K shares in Relay Therapeutics (Ticker: RLAY). Most recently, Peter Rahmer Sold 17,083 shares of Relay Therapeutics on Jul 30, 2025 for an estimated value of $62.95K.
Peter Rahmer Relay Therapeutics (RLAY)Chief Corporate Develpment Officer
Relay Therapeutics (RLAY)
Chief Corporate Develpment Officer
Ranked #931 out of 102,971 Corporate Insiders
Profitable Transactions
21 out of 22 Profitable Transactions
Average Return
+36.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Corporate Develpment Officer
Roles that Peter Rahmer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 29, 2024 - Mar 29, 2025
Return:+67.20%
The most profitable trade made by Peter Rahmer
Peter Rahmer's Trading History
List of latest transactions for each holding click on a transaction to see Peter Rahmer's performance on stock
You May Also Like
Peter Rahmer insider profile FAQ
What is the percentage of profitable transactions made by Peter Rahmer?
The percentage of profitable transactions made by Peter Rahmer is 95%.
What is the average return per transaction made by Peter Rahmer?
The average return per transaction made by Peter Rahmer is 36.80%.
What stocks does Peter Rahmer hold?
Peter Rahmer holds: RLAY stocks.
What was Peter Rahmer’s latest transaction?
Peter Rahmer latest transaction was an Informative Sell of $62.95K.
What was Peter Rahmer's most profitable transaction?
Peter Rahmer’s most profitable transaction was an Informative Sell of RLAY stock on March 29, 2024. The return on the trade was 67.20%.
What is Peter Rahmer's role in Relay Therapeutics?
Peter Rahmer's role in Relay Therapeutics is Chief Corporate Develpment Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.